- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06220409
Gut Microbiota Composition, Cognitive Function, and Physical Fitness in Multiple Sclerosis Patients (MSDANCE)
Effect of Dance Classes on Gut Microbiota Composition, Cognitive Function, and Physical Fitness in Multiple Sclerosis Patients
The evidence suggests that multiple sclerosis (MS) induces a decline in motor and cognitive function and provokes a shift in gut microbiome composition in patients. Therefore, the purpose of this study is to explore the effect of a 12-week dance class training program on the gut microbiota composition, motor function, and cognitive function of patients with MS.
The investigators will also study the following:
- The impact of organised physical activity on quality of life
- The impact of organised physical activity on body composition and metabolic parameters (e.g., insulin sensitivity, lipid profile, ect.)
- The impact of organised physical activity on physical fitness (e.g., VO2max, Power, ect.)
Study Overview
Detailed Description
Progressive loss of lower extremity mobility and physical function is one of the most important and well-researched effects of MS. Additionally, there is evidence that MS patients have a moderate dysbiosis in the gut microbiota structure compared to healthy subjects, whereas recent studies have demonstrated the critical role the gut microbiome plays in preserving general health, including its potential impact on neurological disorders and the immune system. Even though research is still in its early stages, the gut microbiome may have a significant impact on MS. A plethora of physical exercise strategies are available in the literature to help MS patients with fatigue, motor function, and health-related quality of life. Despite the scarcity of specific research, embracing dancing courses for MS patients has promising potential health benefits. Importantly, apart from improved physical fitness and motor function, patients with MS may also experience dancing with various other advantages, such as emotional well-being and social interaction.
Objective: This proposal aims to investigate the effects of regular physical exercise, such as dancing classes, on the health of individuals with MS. MSDANCE will investigate the impact that a dancing class training program lasting twelve weeks had on the makeup of the microbiota in the gut, as well as the motor and cognitive functioning, physical fitness, quality of life, body composition, and metabolic parameters of patients with MS. Consequently, these observations will be compared with those of healthy subjects.
Hypothesis: The investigators hypothesize that regular physical exercise (dance class training program) will improve motor and cognitive functions, with an additional positive effect on the microbial composition in patients with MS. The investigators further hypothesize the improvement in the following variables: physical fitness, quality of life, body composition, metabolic parameters, etc.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bratislava, Slovakia, 814 69
- Department of Biological and Medical Science, Faculty of Physical Education and Sport, Comenius University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- patients with multiple sclerosis, diagnosed according to official diagnostic criteria according to McDonald 2010
- Consent ability and written consent
- The expanded disability status scale (EDSS) <5.5
- age 30 - 50
Exclusion Criteria:
- serious comorbidities including psychiatric diseases
- Significant cognitive impairment, clinically relevant or progressive disease (e.g., liver, kidney, cardiovascular system, respiratory tract, vascular system, brain, metabolism, thyroid) that could affect the course of the study
- Clinically relevant addiction or substance abuse disorder (defined as alcohol, drug and drug abuse)
- Nicotine consumption of > 5 cigarettes per day and no willingness to stop consumption during therapeutic fasting.
- Simultaneous participation in an interventional study or participation in an interventional study in the last two months before study inclusion
- Malignant disease
- Insufficient mental possibility of cooperation Eating disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dance
The patients persuading dance classes two times a wek for 3 months .
|
A 12-week dance class training program two times a week for 3 months
|
No Intervention: Passive
The patients engage in no structured or self-induced physical exercise or activity (sedentary individuals)
|
|
No Intervention: Healthy subjects
The subjects engage in sports recreationally
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The shift in the mean gut microbiota diversity
Time Frame: Change from baseline at 3 months
|
Influence of the interventions on the Shannon index.
The higher the index, the more diverse the species are in the habitat.
The value of the Shannon-Weaver diversity index usually ranges from 1.5 to 3.5 and only rarely exceeds 4.5.
|
Change from baseline at 3 months
|
Change from baseline in the mean quantitative mobility and leg function performance
Time Frame: Change from baseline at 3 months
|
Influence of the interventions on a time in 25-Foot Walk.
The longer the duration, the worse the outcome.
Normal values: less than 4 seconds; Mild impairment: 4-5.99 seconds; Moderate impairment: 6-9.99 seconds; Severe impairment: 10 seconds or more.
|
Change from baseline at 3 months
|
Change from baseline in the mean quantitative upper extremity function performance
Time Frame: Change from baseline at 3 months
|
Influence of the interventions on a 9-hole Peg Test.
The longer the duration, the worse the outcome.
Values: 0 (completed without any delays) or more.
|
Change from baseline at 3 months
|
Differences in the mean quantitative maximal oxygen consumption
Time Frame: Changes from baseline at 3 months
|
Comparison of maximal oxygen consumption (VO2max) within groups (MS pre-intervention vs. post-intervention) and between groups (healthy subjects vs. MS pre- and post-intervention).
The higher the values, the better the outcome.
The general ranges for VO2max in healthy adults are: Average Values: Men: 35-40 ml/kg/min, and Women: 27-31 ml/kg/min; Good Fitness Level: Men: 45-50 ml/kg/min and Women: 38-42 ml/kg/min; Excellent Fitness Level: Men: 55-60 ml/kg/min or higher, and Women: 47-52 ml/kg/min or higher.
|
Changes from baseline at 3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Viktor Bielik, prof., Faculty of Physical Education and Sport, Comenius University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1/0260/21
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sclerosis, Multiple
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingMultiple Sclerosis | Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of MinnesotaMallinckrodtTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
Clinical Trials on Dance classes
-
Wake Forest University Health SciencesRecruitingAlzheimer DiseaseUnited States
-
University of West AtticaCompleted
-
Federal University of Rio Grande do SulAline Nogueira Haas; Flávia Gomes MartinezRecruitingParkinson Disease | Parkinson Disease 10Brazil
-
University of Milano BicoccaRecruitingMild Cognitive Impairment | Subjective Cognitive DeclineItaly
-
Federal University of Rio Grande do SulCompleted
-
Eduardo Lusa CadoreRecruiting
-
St George Hospital, AustraliaThe University of New South Wales; Australian Government Department of Health... and other collaboratorsUnknownOsteoarthritis, Knee | Osteoarthritis, HipAustralia
-
University of California, Los AngelesCompletedDiabetes Mellitus, Type 2United States
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
University of Illinois at ChicagoNational Institute on Aging (NIA)Active, not recruitingMild Cognitive Impairment | Older Adults | Neurological InjuryUnited States